Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
12.04
-0.02 (-0.17%)
At close: Sep 5, 2025, 4:00 PM
12.06
+0.02 (0.17%)
After-hours: Sep 5, 2025, 4:42 PM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $658.03 million as of September 5, 2025.
Market Cap
658.03M
Enterprise Value
223.66M
1-Year Change
n/a
Ranking
Category
Stock Price
12.04
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has decreased from $931.70M to $658.03M, a decrease of -29.37%. That is a compound annual growth rate of -29.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 658.03M | -30.58% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |